Propionate ameliorates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress

Frontiers in Pharmacology

Volumn 7, Issue AUG, 2016, Pages

  Tong, Ling Chang ^a,b   Wang, Yue ^a,c   Wang, Zhi Bin ^b   Liu, Wei Ye ^b   Sun, Sheng ^b   Li, Ling ^b   Su, Ding Feng ^b   Zhang, Li Chao ^a  

^a Shanghai Municipal Hospital of Traditional Chinese Medicine   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Dextran sulfate sodium; Inflammation; Intestinal barrier function; Propionate; Short chain fatty acid; Tight junction protein; Ulcerative colitis

Indexed keywords

CATALASE; CD68 ANTIGEN; DEXTRAN SULFATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; OCCLUDIN; PROPIONATE SODIUM; STAT3 PROTEIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; ENTERITIS; ENZYME BLOOD LEVEL; IN VIVO STUDY; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 84988704536     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00253     Document Type: Article

References (36)

1. Balmus, I. M., Ciobica, A., Trifan, A., and Stanciu, C. (2016). The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: clinical aspects and animal models. Saudi J. Gastroenterol. 22, 3-17. doi: 10.4103/1319-3767.173753
2. Bolognini, D., Tobin, A. B., Milligan, G., and Moss, C. E. (2016). The pharmacology and function of receptors for short-chain fatty acids. Mol. Pharmacol. 89, 388-398. doi: 10.1124/mol.115.102301
3. Cabre, E., and Domenech, E. (2012). Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J. Gastroenterol. 18, 3814-3822. doi: 10.3748/wjg.v18.i29.3814
4. Caprioli, F., Bose, F., Rossi, R. L., Petti, L., Vigano, C., Ciafardini, C., et al. (2013). Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy. Inflamm. Bowel Dis. 19, 729-739. doi: 10.1097/MIB.0b013e318280292b
5. Clausen, M. R., Bonnen, H., and Mortensen, P. B. (1991). Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer. Gut 32, 923-928. doi: 10.1136/gut.32.8.923
6. Colgan, S. P., Curtis, V. F., Lanis, J. M., and Glover, L. E. (2015). Metabolic regulation of intestinal epithelial barrier during inflammation. Tissue Barriers 3:e970936. doi: 10.4161/21688362.2014.970936
7. D'Argenio, G., and Mazzacca, G. (1999). Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv. Exp. Med. Biol. 472, 149-158.
8. Elamin, E. E., Masclee, A. A., Dekker, J., Pieters, H. J., and Jonkers, D. M. (2013). Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J. Nutr. 143, 1872-1881. doi: 10.3945/jn.113.179549
9. Hamer, H. M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F. J., and Brummer, R. J. (2008). Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104-119. doi: 10.1111/j.1365-2036.2007.03562.x
10. Hamer, H. M., Jonkers, D. M., Bast, A., Vanhoutvin, S. A., Fischer, M. A., Kodde, A., et al. (2009). Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin. Nutr. 28, 88-93. doi: 10.1016/j.clnu.2008.11.002
11. Hamer, H. M., Jonkers, D. M., Vanhoutvin, S. A., Troost, F. J., Rijkers, G., De Bruine, A., et al. (2010). Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin. Nutr. 29, 738-744. doi: 10.1016/j.clnu.2010.04.002
12. Han, J., and Theiss, A. L. (2014). Stat3: friend or foe in colitis and colitis-associated cancer? Inflamm. Bowel Dis. 20, 2405-2411. doi: 10.1097/MIB.0000000000000180
13. Hijova, E., and Chmelarova, A. (2007). Short chain fatty acids and colonic health. Bratisl. Lek. Listy 108, 354-358.
14. Hill, M. J. (1995). Bacterial fermentation of complex carbohydrate in the human colon. Eur. J. Cancer Prev. 4, 353-358. doi: 10.1097/00008469-199510000-00004
15. Huang, N., and Wu, G. D. (1997). Short chain fatty acids inhibit the expression of the neutrophil chemoattractant, interleukin 8, in the Caco-2 intestinal cell line. Adv. Exp. Med. Biol. 427, 145-153. doi: 10.1007/978-1-4615-5967-2_16
16. Lee, S. H. (2015). Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest. Res. 13, 11-18. doi: 10.5217/ir.2015.13.1.11
17. Liu, W. Y., Wang, Z. B., Wang, Y., Tong, L. C., Li, Y., Wei, X., et al. (2015). Increasing the permeability of the blood-brain barrier in three different models in vivo. CNS Neurosci. Ther. 21, 568-574. doi: 10.1111/cns.12405
18. Loddo, I., and Romano, C. (2015). Inflammatory bowel disease: genetics, epigenetics, and pathogenesis. Front. Immunol. 6:551. doi: 10.3389/fimmu.2015.00551
19. Mao, R., and Hu, P. J. (2016). The future of IBD therapy: where are we and where should we go next? Dig. Dis. 34, 175-179. doi: 10.1159/000443135
20. Mariadason, J. M., Barkla, D. H., and Gibson, P. R. (1997). Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. Am. J. Physiol. 272, G705-G712.
21. Mariadason, J. M., Catto-Smith, A., and Gibson, P. R. (1999). Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats. Gut 44, 394-399. doi: 10.1136/gut.44.3.394
22. Meijer, K., De Vos, P., and Priebe, M. G. (2010). Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr. Opin. Clin. Nutr. Metab. Care 13, 715-721. doi: 10.1097/MCO.0b013e32833eebe5
23. Moussaoui, N., Braniste, V., Ait-Belgnaoui, A., Gabanou, M., Sekkal, S., Olier, M., et al. (2014). Changes in intestinal glucocorticoid sensitivity in early life shape the risk of epithelial barrier defect in maternal-deprived rats. PLoS ONE 9:e88382. doi: 10.1371/journal.pone.0088382
24. Nguyen, P. M., Putoczki, T. L., and Ernst, M. (2015). STAT3-activating cytokines: a therapeutic opportunity for inflammatory bowel disease? J. Interferon Cytokine Res. 35, 340-350. doi: 10.1089/jir.2014.0225
25. Peng, L., He, Z., Chen, W., Holzman, I. R., and Lin, J. (2007). Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 61, 37-41. doi: 10.1203/01.pdr.0000250014.92242.f3
26. Piechota-Polanczyk, A., and Fichna, J. (2014). Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn Schmiedebergs Arch. Pharmacol. 387, 605-620. doi: 10.1007/s00210-014-0985-1
27. Quetglas, E. G., Mujagic, Z., Wigge, S., Keszthelyi, D., Wachten, S., Masclee, A., et al. (2015). Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World J. Gastroenterol. 21, 12519-12543. doi: 10.3748/wjg.v21.i44.12519
28. Roessner, A., Kuester, D., Malfertheiner, P., and Schneider-Stock, R. (2008). Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol. Res. Pract. 204, 511-524. doi: 10.1016/j.prp.2008.04.011
29. Sánchez de Medina, F., Romero-Calvo, I., Mascaraque, C., and Martinez-Augustin, O. (2014). Intestinal inflammation and mucosal barrier function. Inflamm. Bowel Dis. 20, 2394-2404. doi: 10.1097/MIB.0000000000000204
30. Suzuki, T., Yoshida, S., and Hara, H. (2008). Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br. J. Nutr. 100, 297-305. doi: 10.1017/S0007114508888733
31. Tedelind, S., Westberg, F., Kjerrulf, M., and Vidal, A. (2007). Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol. 13, 2826-2832.
32. Van Deun, K., Pasmans, F., Van Immerseel, F., Ducatelle, R., and Haesebrouck, F. (2008). Butyrate protects Caco-2 cells from Campylobacter jejuni invasion and translocation. Br. J. Nutr. 100, 480-484. doi: 10.1017/S0007114508921693
33. Vinolo, M. A., Rodrigues, H. G., Hatanaka, E., Sato, F. T., Sampaio, S. C., and Curi, R. (2011). Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22, 849-855. doi: 10.1016/j.jnutbio.2010.07.009
34. Wang, H., Shi, P., Zuo, L., Dong, J., Zhao, J., Liu, Q., et al. (2016). Dietary non-digestible polysaccharides ameliorates intestinal epithelial barrier dysfunction in IL-10 knockout mice. J. Crohns Colitis doi: 10.1093/ecco-jcc/jjw065 [Epub ahead of print].
35. Wirtz, S., Neufert, C., Weigmann, B., and Neurath, M. F. (2007). Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541-546. doi: 10.1038/nprot.2007.41
36. Zhang, L. C., Li, Z. Z., Yu, Y. S., Wang, Z. B., Wei, X., Su, D. F., et al. (2011). Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 are involved in sinoaortic denervation-induced cardiovascular hypertrophy in rats. Biol. Pharm. Bull. 34, 1398-1403. doi: 10.1248/bpb.34.1398